Gene Symbol | PXYLP1 |
---|---|
Entrez Gene | 92370 |
Alt Symbol | ACPL2, HEL124, XYLP |
Species | Human |
Gene Type | protein-coding |
Description | 2-phosphoxylose phosphatase 1 |
Other Description | acid phosphatase-like 2|acid phosphatase-like protein 2|epididymis luminal protein 124|xylosyl phosphatase |
Swissprots | Q8TE99 D3DNF5 W0TR04 Q49AJ2 |
Accessions | EAW79007 EAW79008 EAW79009 Q8TE99 AB827640 BAO45795 AK074331 BAB85053 AK296292 BAH12305 AK297790 BAH12668 AK316121 BAH14492 AL137529 CAB70793 AY358460 AAQ88825 BC035834 AAH35834 BC036701 AAH36701 BX647621 CA421956 CD101677 CX762355 DC409719 EU794677 ACJ13731 XM_005247903 XP_005247960 XM_011513314 XP_011511616 XM_011513315 XP_011511617 XM_011513316 XP_011511618 NM_001037172 NP_001032249 NM_001282728 NP_001269657 NM_152282 NP_689495 |
Function | Responsible for the 2-O-dephosphorylation of xylose in the glycosaminoglycan-protein linkage region of proteoglycans thereby regulating the amount of mature glycosaminoglycan (GAG) chains. Sulfated glycosaminoglycans (GAGs), including heparan sulfate and chondroitin sulfate, are synthesized on the so-called common GAG-protein linkage region (GlcUAbeta1-3Galbeta1-3Galbeta1- 4Xylbeta1-O-Ser) of core proteins, which is formed by the stepwise addition of monosaccharide residues by the respective specific glycosyltransferases. Xylose 2-O-dephosphorylation during completion of linkage region formation is a prerequisite for the initiation and efficient elongation of the repeating disaccharide region of GAG chains. {ECO:0000269|PubMed:24425863}. |
Subcellular Location | Golgi apparatus membrane {ECO:0000269|PubMed:24425863}; Single-pass type II membrane protein {ECO:0000255}. Note=Colocalizes to Golgi apparatus in a B3GAT3-dependent manner. {ECO:0000269|PubMed:24425863}. |
Tissue Specificity | Widely expressed. Strongly expressed in spleen, fetal liver, moderately in placenta, pancreas, kidney, thymus and colon. {ECO:0000269|PubMed:24425863}. |
ACPL2 (H-4) - sc-377262 from Santa Cruz Biotechnology
|
||||||||
ACPL2 (K-13) - sc-102291 from Santa Cruz Biotechnology
|
||||||||
ACPL2 (N-18) - sc-102292 from Santa Cruz Biotechnology
|
||||||||
Anti-ACPL2 antibody - ab100850 from Abcam
|
||||||||
Anti-ACPL2 antibody - ab124190 from Abcam
|
||||||||
Anti-PXYLP1 / ACPL2 Antibody - LS-C137298 from LifeSpan Bioscience
|
||||||||
Anti-PXYLP1 / ACPL2 Antibody (aa306-335, AP) - LS-C221335 from LifeSpan Bioscience
|
||||||||
Anti-PXYLP1 / ACPL2 Antibody (aa306-335, APC) - LS-C221336 from LifeSpan Bioscience
|
||||||||
Anti-PXYLP1 / ACPL2 Antibody (aa306-335, Biotin) - LS-C221338 from LifeSpan Bioscience
|
||||||||
Anti-PXYLP1 / ACPL2 Antibody (aa306-335, Azide-free, HRP) - LS-C221339 from LifeSpan Bioscience
|
||||||||
Anti-PXYLP1 / ACPL2 Antibody (aa306-335, PE) - LS-C221340 from LifeSpan Bioscience
|
||||||||
Anti-PXYLP1 / ACPL2 Antibody (aa306-335) - LS-C319291 from LifeSpan Bioscience
|
||||||||
Anti-PXYLP1 / ACPL2 Antibody (aa306-335, FITC) - LS-C221337 from LifeSpan Bioscience
|
||||||||
Anti-PXYLP1 / ACPL2 Antibody (aa71-120) - LS-C110988 from LifeSpan Bioscience
|
||||||||
Anti-PXYLP1 / ACPL2 Antibody (aa143-192) - LS-C110989 from LifeSpan Bioscience
|
||||||||
Anti-PXYLP1 / ACPL2 Antibody (aa306-335) - LS-C155962 from LifeSpan Bioscience
|
||||||||
ACPL2 Antibody - NBP1-59508 from Novus Biologicals
|
||||||||
ACPL2 Antibody - NBP1-59507 from Novus Biologicals
|
||||||||
ACPL2 Antibody - NBP1-83577 from Novus Biologicals
|
||||||||
ACPL2 Polyclonal Antibody - bs-9348R from Bioss
|
||||||||
Anti-ACPL2, (N-terminal) antibody produced in rabbit - SAB2103919 from Sigma-Aldrich
|
||||||||
Anti-ACPL2 antibody produced in rabbit - HPA017243 from Sigma-Aldrich
|
||||||||
Anti-ACPL2 antibody produced in rabbit - SAB2103920 from Sigma-Aldrich
|
||||||||
ACPL2 antibody - N-terminal region (ARP44835_P050) - ARP44835_P050 from Aviva Systems Biology
|
||||||||
ACPL2 antibody - middle region (ARP44836_P050) - ARP44836_P050 from Aviva Systems Biology
|